Dihydropyridines (Calcium Channel Blockers)

What are Dihydropyridines?

Dihydropyridines are a class of calcium channel blockers that bind to high-voltage L-type channels on vascular smooth muscle to block calcium-triggered contraction. This action leads to arteriolar dilation—the widening of small arteries—which reduces afterload while sparing conduction in the atrioventricular (AV) node. Afterload represents the resistance the heart must pump against to eject blood.

Clinical guidelines recommend this calcium channel blocker therapy for hypertension, especially in individuals with coronary disease or isolated systolic elevations. They are particularly effective for individuals older than 60. The dihydropyridines class includes amlodipine, nifedipine, and similar agents. These calcium channel blockers maintain their efficacy even when renal function declines, making them useful for individuals with chronic kidney disease. A dihydropyridine calcium blocker, such as amlodipine, may substitute for thiazide diuretics when metabolic concerns exist.

What is the mechanism of action of Dihydropyridines?

The dihydropyridine calcium antagonist subclass of calcium channel blockers stabilizes the high-voltage L-type channel in its inactive state to prolong muscle relaxation. This effect limits the activation of myosin light-chain kinase by calcium-calmodulin, which is the primary mechanism of action of calcium blockers.

By reducing vascular resistance while keeping myocardial oxygen demand stable, calcium channel blockers effectively manage blood pressure. Recognizing the differences between nondihydropyridine and dihydropyridine profiles helps clinicians match therapy to specific comorbidities. While dihydropyridine agents focus on the vasculature, non-dihydropyridine calcium channel blockers primarily affect heart nodal conduction. Understanding how calcium channel blockers work highlights the reduction of calcium influx to induce vessel relaxation.

For example, amlodipine features a slow onset with a long half-life, allowing for once-daily dosing. In contrast, nicardipine provides rapid arterial relaxation, making it ideal for acute hypertensive crises. Different dihydropyridines vary mainly in the onset and duration of vasodilatory effect rather than in effects on cardiac conduction.

What are the clinical uses (Indications) of Dihydropyridines?

Dihydropyridine calcium channel blockers serve as first-line treatments for hypertension, especially in elderly and African American adults with isolated systolic elevations. They are also used to relieve chronic stable angina and variant angina by reducing afterload and preventing coronary vasospasm, which is the sudden tightening of the heart’s arteries.

If blood pressure goals are not met, a dihydropyridine is more commonly combined with antihypertensives from other drug classes. Intravenous dihydropyridine agents, such as clevidipine or nicardipine, are used for controlled blood pressure reduction during hypertensive emergencies. Oral dihydropyridines are also used for vasospastic angina.

What are the adverse effects and contraindications of Dihydropyridines?

Common side effects include dose-dependent peripheral edema—swelling of the legs or ankles—headache, flushing, and reflex tachycardia. Reflex tachycardia is a rapid heart rate resulting from the body’s response to rapid arteriolar dilation. These effects often worsen when doses exceed those needed for blood pressure control or when the drugs are combined with other vasodilators. Gingival hyperplasia, or overgrowth of the gums, may also develop, particularly with the use of nifedipine.

Clinicians should use caution in individuals with severe aortic stenosis, and short-acting dihydropyridines should generally be avoided because they can cause marked hypotension and reflex tachycardia. Clinically significant bradycardia and atrioventricular conduction slowing are concerns mainly with nondihydropyridine calcium channel blockers, not with dihydropyridines.

What are some examples of Dihydropyridines?

The following calcium channel blocker examples illustrate the predominant choices between the two subclasses. This list of Ca channel blockers emphasizes the most common dihydropyridine Ca channel blockers used in clinical practice.

Dihydropyridines (DHP)	Non-Dihydropyridines (Non-DHP)
Amlodipine	Verapamil
Nifedipine	Diltiazem
Nicardipine
Felodipine
Clevidipine
Isradipine

What are the most important facts to know about Dihydropyridines?

• Dihydropyridine calcium channel blockers primarily dilate arterioles and are a mainstay of hypertension therapy, particularly in older adults.
• The mechanism of action differs by subclass: dihydropyridine agents block vascular L-type channels, while nondihydropyridine agents target the heart’s conduction nodes.
• These drugs are indicated for hypertension, chronic stable angina, and hypertensive emergencies, and they are useful in patients with chronic kidney disease.
• Clinicians must monitor for side effects, including peripheral edema, reflex tachycardia, and gingival hyperplasia.
• Examples of common calcium channel blockers include amlodipine, nifedipine, and nicardipine, which must be distinguished from non-DHP agents like verapamil and diltiazem.